ICD-10-CM 2027 diagnosis code
T39.1X2APoisoning by 4-Aminophenol derivatives, intentional self-harm, initial encounter
T39.1X2A is a valid, billable ICD-10-CM code for poisoning by 4-aminophenol derivatives, intentional self-harm, initial encounter. It can be reported on claims for dates of service from October 1, 2026 – September 30, 2027.Short description: Poisoning by 4-Aminophenol derivatives, self-harm, init
Code unchanged since ICD-10-CM took effect on October 1, 2015. Source: official FY2027 ICD-10-CM release from CDC/NCHS and CMS. Page updated September 29, 2026. About our data
About T39.1X2A
T39.1X2A is the ICD-10-CM diagnosis code for poisoning by 4-Aminophenol derivatives, intentional self-harm, initial encounter. It belongs to category T39 (poisoning by, adverse effect of and underdosing of nonopioid analgesics, antipyretics and antirheumatics), block T36-T50 (poisoning by, adverse effects of and underdosing of drugs, medicaments and biological substances) and chapter 19 (injury, poisoning and certain other consequences of external causes). It is billable, so it can be reported on its own for dates of service from October 1, 2026 through September 30, 2027.
The 7th character "A" means initial encounter: use it while the patient is receiving active treatment for the condition.
It is not a CC or MCC, so as a secondary diagnosis it doesn't change the MS-DRG severity level.
In MS-DRG v44.0, it is part of the grouping logic for DRG 917 (Poisoning and Toxic Effects of Drugs with MCC, relative weight 1.57) and DRG 918 (Poisoning and Toxic Effects of Drugs without MCC, relative weight 0.872), in MDC 21 (Injuries, Poisonings and Toxic Effects of Drugs), as a principal or secondary diagnosis. The DRG a claim lands in depends on the principal diagnosis, procedures and any CC/MCC secondary diagnoses.
It has been part of ICD-10-CM since the code set took effect on October 1, 2015 and hasn't changed since.
Before ICD-10, this condition was coded in ICD-9-CM as 965.4 (poisoning by aromatic analgesics, not elsewhere classified) and E950.0 (suicide and self-inflicted poisoning by analgesics, antipyretics, and antirheumatics).
7th character
Ainitial encounter
Other encounter types for T39.1X2:
Notes that apply from higher levels
Instructions written at a parent level also apply to T39.1X2A.
MS-DRG v44.0 grouping
All DRGs →Inpatient MS-DRGs this diagnosis can group to, as the principal or a secondary diagnosis, depending on the rest of the claim.
MDC 21 · Injuries, Poisonings and Toxic Effects of Drugs
ICD-9-CM equivalent
Converter →- 965.4Poisoning by aromatic analgesics, not elsewhere classifiedapproximate, combination
- E950.0Suicide and self-inflicted poisoning by analgesics, antipyretics, and antirheumaticsapproximate, combination
From the CMS 2018 General Equivalence Mappings (GEMs), the final GEMs release.
Code history
- 2016
- 2017
- 2018
- 2019
- 2020
- 2021
- 2022
- 2023
- 2024
- 2025
- 2026
- 2027
- FY2016 (effective 10/1/2015): Added (first year of ICD-10-CM)
- No changes since FY2016.
Common questions about T39.1X2A
Is T39.1X2A billable?
- Yes. T39.1X2A is a billable/specific ICD-10-CM code valid for FY2027 (October 1, 2026 – September 30, 2027).
What does the "A" at the end of T39.1X2A mean?
- It is the 7th character for initial encounter. Per the official guidelines, use it while the patient is receiving active treatment for the condition.
Can T39.1X2A be used as a principal diagnosis?
- Yes. The Medicare Code Editor doesn't restrict T39.1X2A as a principal diagnosis.
Is T39.1X2A a CC or MCC?
- No. T39.1X2A is neither a CC nor an MCC under MS-DRG v44.0.
What DRG does T39.1X2A group to?
- T39.1X2A is used in the MS-DRG v44.0 logic for MS-DRG 917 (Poisoning and Toxic Effects of Drugs with MCC) and MS-DRG 918 (Poisoning and Toxic Effects of Drugs without MCC). Which one applies depends on whether it is the principal diagnosis and on the rest of the claim.
What is the ICD-9 code for T39.1X2A?
- The CMS General Equivalence Mappings map T39.1X2A to ICD-9-CM 965.4 and E950.0.